Completed PHASE2 INTERVENTIONAL 4-arm NCT02685618

Endothelial Dysfunction in Resuscitated Cardiac Arrest (ENDO-RCA)

Safety and Efficacy of Low-dose Prostacyclin Administration and Blood Pressure Target in Addition to Standard Therapy, as Compared to Standard Therapy Alone, in Post-cardiac-arrest-syndrome Patients - a Randomized, Controlled, Double-blinded Investigator-initiated Trial.

Sponsor: Pär Johansson

Conditions Cardiac Arrest

Interventions Iloprost Philips M1006B, No offset Phillips M1006B, offset by -10mmHg Saline

Updated 7 times since 2017 Last updated: Mar 9, 2021 Started: Feb 29, 2016 Primary completion: Aug 27, 2016 Completion: Feb 27, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Cardiac Arrest and is currently completed. Pär Johansson leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Apr 2021 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Dec 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Jan 2017 — Dec 2017 [monthly]

Active Not Recruiting PHASE2

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pär Johansson

Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark